Although the traditional determinant of renal dysfunction in heart failure was suggested as decreased cardiac output and renal hypo perfusion, recent studies have demonstrated the association of persistent systemic venous congestion and kidney dysfunction. Relief of the congestion has demonstrated to improve renal functions in decompensated heart failure. The current trial was set up to investigate the changes of renal venous impedance and renal arteriolar resistivity indices with diuretic therapy, in patients with congestive renal failure. The investigators asked whether measurement of renal venous impedance index or renal arteriolar resistivity index can guide the practice of diuretic therapy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
60
Decongestant therapy for decompensated heart failure which may be administrated as intravenous bolus or infusion
Ankara University School Of Medicine, Department of Cardiology
Ankara, Turkey (Türkiye)
Alterations in the renal arterial resistivity index
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time frame: during hospitalization, an expected average of 4 weeks.
Alterations in the renal venous impedance index
Participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Time frame: during hospitalization, an expected average of 4 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.